Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	119 Pages	TechSci Research	April, 2023	TCSI17854822

Best Price Guarantee
Price	from $4,900
Length	119 Pages
Publisher	TechSci Research
Published Date	April, 2023
SKU	TCSI17854822

Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

The global diabetic foot ulcer treatment market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasingly leading sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless Treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe, which is susceptible to different kinds of ulcer diseases like foot ulcers, is further expected to increase the demand for different dental contouring procedures, thereby fuelling the market growth through 2028. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period. Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States, and 26.4 million people aged 65 years or older (48.8%) have prediabetes.

Growing Prevalence of Diabetic Foot Ulcer

The rapidly increasing geriatric population is highly susceptible to chronic diseases such as different types of ulcers. This factor is expected to propel the diabetic foot ulcer treatment market in the next few years. An increase in the prevalence of peripheral vascular as well as sugar-related diseases and other chronic diseases leading to a rising risk of hospital-acquired pressure ulcers is expected to drive the segment during the forecast period. Constantly increasing obesity and peripheral artery diseases among developed and developing countries lead to decreased mobility and increased risk of acquiring chronic ulcers. Similarly, leading unhealthy lifestyles due to consuming junk food and alcohol, people are affected with obesity and diabetes, which will further create ulcers and enhance the growth of the market during the forecast period. In 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents. Diabetic foot ulcers are more common because of the growing incidence in both types of I and maturity-onset diabetes among the aging population in the developing region, which will further propel the growth of the market during the forecast period.

Technological Advancement

Increasing investment and initiative by a government organization for research and development sectors is a major factor driving the market across the globe. An increase in the development of new treatments and advancement in diabetic foot ulcers is expected to create significant growth in the forecast period. For instance, in July 2019, AVITA Medical, g global regenerative medicine company, announced favorable results from an open-label feasibility study of the RECELL Autologous Cell Harvesting Device for the Treatment of Diabetic Foot Ulcers. Increasingly better hospital facility boosts the number of people opting for diabetic foot ulcer treatment. Advanced wound care is rapidly growing, which will further attract new players to invest in this market. Growing development in new biologic products, innovation, and research in skin grafts will further drive the growth of the market over the years.

Market Segmentation

The global diabetic foot ulcer treatment market can be segmented by Treatment, ulcer treatment, End User, and by region. Based on Treatment, the market can be segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others. Based on ulcer treatment, the market can be differentiated into Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers. Based on End Users, the market can be grouped into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global diabetic foot ulcer treatment market.

Recent Development

In January 2019, UPM launched a new advanced wound care product in the European market, and FibDex is the product for wound dressing, created from wood-based nano fibrillar cellulose, to receive regulatory approval and to be awarded a CE mark.

Market Players

3M Company, Medtronic Plc, ConvaTec, Inc., Coloplast Corporation, Smith & Nephew Plc, B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Molnlycke Health Care AB, Acelity L.P., Inc. are some of the leading players operating in the Global Diabetic Foot Ulcer Treatment Market.

Report Scope:

In this report, global diabetic foot ulcer treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Diabetic Foot Ulcer Treatment Market, By Treatment:
Wound Care Dressings
Biologics
Therapy Devices
Antibiotic Medications
Others
Diabetic Foot Ulcer Treatment Market, By Ulcer Treatment:
Neuropathic Ulcers
Ischemic Ulcers
Neuroischemic Ulcers
Diabetic Foot Ulcer Treatment Market, By End User:
Hospitals & Clinics
Ambulatory Care Centers
Others
Diabetic Foot Ulcer Treatment Market, By Region:
North America
United States
Canada
Mexico
Europe
France
Germany
United Kingdom
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Diabetic Foot Ulcer Treatment Market.

Company Information

Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights

1. Product Overview: 1.1. Market Definition; 1.2. Scope of the Market; 1.2.1. Markets Covered; 1.2.2. Years Considered for Study; 1.2.3. Key Market Segmentations
2. Research Methodology: 2.1. Objective of the Study; 2.2. Baseline Methodology; 2.3. Key Industry Partners; 2.4. Major Association and Secondary Sources; 2.5. Forecasting Methodology; 2.6. Data Triangulation & Validation; 2.7. Assumptions and Limitations
3. Executive Summary: 3.1. Overview of the Market; 3.2. Overview of Key Market Segmentations; 3.3. Overview of Key Market Players; 3.4. Overview of Key Regions/Countries; 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Diabetic Foot Ulcer Treatment Market Outlook: 5.1. Market Size & Forecast; 5.1.1. By Value; 5.2. Market Share & Forecast; 5.2.1. By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others); 5.2.2. By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers); 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others); 5.2.4. By Region; 5.2.5. By Company (2022); 5.3. Market Map; 5.3.1. By Treatment; 5.3.2. By Ulcer Type; 5.3.3. By End User; 5.3.4. By Region
6. North America Diabetic Foot Ulcer Treatment Market Outlook: 6.1. Market Size & Forecast; 6.1.1. By Value; 6.2. Market Share & Forecast; 6.2.1. By Treatment; 6.2.2. By Ulcer Type; 6.2.3. By End User; 6.2.4. By Country; 6.3. North America: Country Analysis; 6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook; 6.3.1.1. Market Size & Forecast; 6.3.1.1.1. By Value; 6.3.1.2. Market Share & Forecast; 6.3.1.2.1. By Treatment; 6.3.1.2.2. By Ulcer Type; 6.3.1.2.3. By End User; 6.3.2. Canada Diabetic Foot Ulcer Treatment Market Outlook; 6.3.2.1. Market Size & Forecast; 6.3.2.1.1. By Value; 6.3.2.2. Market Share & Forecast; 6.3.2.2.1. By Treatment; 6.3.2.2.2. By Ulcer Type; 6.3.2.2.3. By End User; 6.3.3. Mexico Diabetic Foot Ulcer Treatment Market Outlook; 6.3.3.1. Market Size & Forecast; 6.3.3.1.1. By Value; 6.3.3.2. Market Share & Forecast; 6.3.3.2.1. By Treatment; 6.3.3.2.2. By Ulcer Type; 6.3.3.2.3. By End User
7. Europe Diabetic Foot Ulcer Treatment Market Outlook: 7.1. Market Size & Forecast; 7.1.1. By Value; 7.2. Market Share & Forecast; 7.2.1. By Treatment; 7.2.2. By Ulcer Type; 7.2.3. By End User; 7.2.4. By Country; 7.3. Europe: Country Analysis; 7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook; 7.3.1.1. Market Size & Forecast; 7.3.1.1.1. By Value; 7.3.1.2. Market Share & Forecast; 7.3.1.2.1. By Treatment; 7.3.1.2.2. By Ulcer Type; 7.3.1.2.3. By End User; 7.3.2. Germany Diabetic Foot Ulcer Treatment Market Outlook; 7.3.2.1. Market Size & Forecast; 7.3.2.1.1. By Value; 7.3.2.2. Market Share & Forecast; 7.3.2.2.1. By Treatment; 7.3.2.2.2. By Ulcer Type; 7.3.2.2.3. By End User; 7.3.3. United Kingdom Diabetic Foot Ulcer Treatment Market Outlook; 7.3.3.1. Market Size & Forecast; 7.3.3.1.1. By Value; 7.3.3.2. Market Share & Forecast; 7.3.3.2.1. By Treatment; 7.3.3.2.2. By Ulcer Type; 7.3.3.2.3. By End User; 7.3.4. Italy Diabetic Foot Ulcer Treatment Market Outlook; 7.3.4.1. Market Size & Forecast; 7.3.4.1.1. By Value; 7.3.4.2. Market Share & Forecast; 7.3.4.2.1. By Treatment; 7.3.4.2.2. By Ulcer Type; 7.3.4.2.3. By End User; 7.3.5. Spain Diabetic Foot Ulcer Treatment Market Outlook; 7.3.5.1. Market Size & Forecast; 7.3.5.1.1. By Value; 7.3.5.2. Market Share & Forecast; 7.3.5.2.1. By Treatment; 7.3.5.2.2. By Ulcer Type; 7.3.5.2.3. By End User
8. Asia-Pacific Diabetic Foot Ulcer Treatment Market Outlook: 8.1. Market Size & Forecast; 8.1.1. By Value; 8.2. Market Share & Forecast; 8.2.1. By Treatment; 8.2.2. By Ulcer Type; 8.2.3. By End User; 8.2.4. By Country; 8.3. Asia-Pacific: Country Analysis; 8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook; 8.3.1.1. Market Size & Forecast; 8.3.1.1.1. By Value; 8.3.1.2. Market Share & Forecast; 8.3.1.2.1. By Treatment; 8.3.1.2.2. By Ulcer Type; 8.3.1.2.3. By End User; 8.3.2. India Diabetic Foot Ulcer Treatment Market Outlook; 8.3.2.1. Market Size & Forecast; 8.3.2.1.1. By Value; 8.3.2.2. Market Share & Forecast; 8.3.2.2.1. By Treatment; 8.3.2.2.2. By Ulcer Type; 8.3.2.2.3. By End User; 8.3.3. Japan Diabetic Foot Ulcer Treatment Market Outlook; 8.3.3.1. Market Size & Forecast; 8.3.3.1.1. By Value; 8.3.3.2. Market Share & Forecast; 8.3.3.2.1. By Treatment; 8.3.3.2.2. By Ulcer Type; 8.3.3.2.3. By End User; 8.3.4. South Korea Diabetic Foot Ulcer Treatment Market Outlook; 8.3.4.1. Market Size & Forecast; 8.3.4.1.1. By Value; 8.3.4.2. Market Share & Forecast; 8.3.4.2.1. By Treatment; 8.3.4.2.2. By Ulcer Type; 8.3.4.2.3. By End User; 8.3.5. Australia Diabetic Foot Ulcer Treatment Market Outlook; 8.3.5.1. Market Size & Forecast; 8.3.5.1.1. By Value; 8.3.5.2. Market Share & Forecast; 8.3.5.2.1. By Treatment; 8.3.5.2.2. By Ulcer Type; 8.3.5.2.3. By End User
9. South America Diabetic Foot Ulcer Treatment Market Outlook: 9.1. Market Size & Forecast; 9.1.1. By Value; 9.2. Market Share & Forecast; 9.2.1. By Treatment; 9.2.2. By Ulcer Type; 9.2.3. By End User; 9.2.4. By Country; 9.3. South America: Country Analysis; 9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook; 9.3.1.1. Market Size & Forecast; 9.3.1.1.1. By Value; 9.3.1.2. Market Share & Forecast; 9.3.1.2.1. By Treatment; 9.3.1.2.2. By Ulcer Type; 9.3.1.2.3. By End User; 9.3.2. Argentina Diabetic Foot Ulcer Treatment Market Outlook; 9.3.2.1. Market Size & Forecast; 9.3.2.1.1. By Value; 9.3.2.2. Market Share & Forecast; 9.3.2.2.1. By Treatment; 9.3.2.2.2. By Ulcer Type; 9.3.2.2.3. By End User; 9.3.3. Colombia Diabetic Foot Ulcer Treatment Market Outlook; 9.3.3.1. Market Size & Forecast; 9.3.3.1.1. By Value; 9.3.3.2. Market Share & Forecast; 9.3.3.2.1. By Treatment; 9.3.3.2.2. By Ulcer Type; 9.3.3.2.3. By End User
10. Middle East and Africa Diabetic Foot Ulcer Treatment Market Outlook: 10.1. Market Size & Forecast; 10.1.1. By Value; 10.2. Market Share & Forecast; 10.2.1. By Treatment; 10.2.2. By Ulcer Type; 10.2.3. By End User; 10.2.4. By Country; 10.3. MEA: Country Analysis; 10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook; 10.3.1.1. Market Size & Forecast; 10.3.1.1.1. By Value; 10.3.1.2. Market Share & Forecast; 10.3.1.2.1. By Treatment; 10.3.1.2.2. By Ulcer Type; 10.3.1.2.3. By End User; 10.3.2. Saudi Arabia Diabetic Foot Ulcer Treatment Market Outlook; 10.3.2.1. Market Size & Forecast; 10.3.2.1.1. By Value; 10.3.2.2. Market Share & Forecast; 10.3.2.2.1. By Treatment; 10.3.2.2.2. By Ulcer Type; 10.3.2.2.3. By End User; 10.3.3. UAE Diabetic Foot Ulcer Treatment Market Outlook; 10.3.3.1. Market Size & Forecast; 10.3.3.1.1. By Value; 10.3.3.2. Market Share & Forecast; 10.3.3.2.1. By Treatment; 10.3.3.2.2. By Ulcer Type; 10.3.3.2.3. By End User; 10.3.4. Turkey Diabetic Foot Ulcer Treatment Market Outlook; 10.3.4.1. Market Size & Forecast; 10.3.4.1.1. By Value; 10.3.4.2. Market Share & Forecast; 10.3.4.2.1. By Treatment; 10.3.4.2.2. By Ulcer Type; 10.3.4.2.3. By End User; 10.3.5. Egypt Diabetic Foot Ulcer Treatment Market Outlook; 10.3.5.1. Market Size & Forecast; 10.3.5.1.1. By Value; 10.3.5.2. Market Share & Forecast; 10.3.5.2.1. By Treatment; 10.3.5.2.2. By Ulcer Type; 10.3.5.2.3. By End User
11. Market Dynamics: 11.1. Drivers; 11.2. Challenges
12. Market Trends & Developments: 12.1. Recent Developments; 12.2. Mergers & Acquisitions; 12.3. Product Launches
13. Competitive Landscape: 13.1. Business Overview; 13.2. Product Offerings; 13.3. Recent Developments; 13.4. Financials (As Reported); 13.5. Key Personnel; 13.6. SWOT Analysis; 13.6.1. 3M Company; 13.6.2. Medtronic Plc; 13.6.3. ConvaTec, Inc.; 13.6.4. Coloplast Corporation; 13.6.5. Smith & Nephew Plc; 13.6.6. B Braun Melsungen AG; 13.6.7. Medline Industries, Inc.; 13.6.8. Organogenesis, Inc.; 13.6.9. Molnlycke Health Care AB; 13.6.10. Acelity L.P., Inc.
14. Strategic Recommendations